Casi Pharmaceuticals Inc (CASI)
2.32 x 1 2.45 x 127
Post-market by (Cboe BZX)
2.43 +0.17 (+7.52%) 03/18/25 [NASDAQ]
2.32 x 1 2.45 x 127
Post-market 2.43 unch (unch) 16:00 ET
for Tue, Mar 18th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,471 | -10,770 | -9,454 | -7,206 | -26,202 |
| Depreciation Amortization | 1,671 | 118 | 67 | 68 | 48 |
| Accounts receivable | N/A | N/A | N/A | 24 | -24 |
| Accounts payable and accrued liabilities | -1,097 | 849 | 181 | 130 | 352 |
| Other Working Capital | -9,782 | 3,572 | 348 | 36 | 274 |
| Other Operating Activity | 8,095 | -172 | 2,835 | 1,435 | 21,557 |
| Operating Cash Flow | $-28,584 | $-6,402 | $-6,023 | $-5,513 | $-3,995 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,130 | -935 | -65 | -25 | -232 |
| Net Acquisitions | -20,643 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -235 |
| Investing Cash Flow | $-21,773 | $-935 | $-65 | $-25 | $-466 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 93,209 | 24,197 | 28,146 | N/A | N/A |
| Other Financing Activity | -939 | -463 | -97 | 0 | 0 |
| Financing Cash Flow | $92,270 | $23,734 | $28,050 | $0 | $N/A |
| Exchange Rate Effect | -1,198 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 43,490 | 27,093 | 5,131 | 10,670 | 15,132 |
| End Cash Position | 84,205 | 43,490 | 27,093 | 5,131 | 10,670 |
| Net Cash Flow | $40,715 | $16,397 | $21,962 | $-5,539 | $-4,462 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,584 | -6,402 | -6,023 | -5,513 | -3,995 |
| Capital Expenditure | -1,131 | -935 | -223 | -25 | -232 |
| Free Cash Flow | -29,715 | -7,337 | -6,246 | -5,539 | -4,227 |